.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Healthtrust
Accenture
McKesson
US Army
Argus Health
Chinese Patent Office
Covington
AstraZeneca

Generated: November 17, 2017

DrugPatentWatch Database Preview

ARISTOCORT A Drug Profile

« Back to Dashboard

Which patents cover Aristocort A, and when can generic versions of Aristocort A launch?

Aristocort A is a drug marketed by Astellas and is included in ten NDAs.

The generic ingredient in ARISTOCORT A is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Medical Subject Heading (MeSH) Categories for ARISTOCORT A

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas
ARISTOCORT A
triamcinolone acetonide
CREAM;TOPICAL083015-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
OINTMENT;TOPICAL080745-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
CREAM;TOPICAL088818-001Oct 16, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
OINTMENT;TOPICAL080750-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
CREAM;TOPICAL083016-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
CREAM;TOPICAL083017-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
CREAM;TOPICAL088820-001Oct 16, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
CREAM;TOPICAL088819-001Oct 16, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
OINTMENT;TOPICAL088781-001Oct 5, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
OINTMENT;TOPICAL088780-001Oct 1, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
Baxter
Cipla
Fish and Richardson
Federal Trade Commission
Colorcon
UBS
Chinese Patent Office
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot